In this section

Efficacy and safety of secukinumab in moderate to severe palmoplantar pustular psoriasis over 148 weeks: Extension of the 2PRECISE study

Mrowietz, U., Bachelez, H., Burden, A. D., Rissler, M., Sieder, C., Orsenigo, R. and Jagiello, P. (2021) Efficacy and safety of secukinumab in moderate to severe palmoplantar pustular psoriasis over 148 weeks: Extension of the 2PRECISE study. Journal of the American Academy of Dermatology, 84(2), pp. 552-554. (doi: 10.1016/j.jaad.2020.06.038) (PMID:32565211)

[img] Text
232186.pdf - Published Version
Available under License Creative Commons Attribution Non-commercial No Derivatives.
472kB

Abstract

No abstract available.

Item Type:Articles (Letter)
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Burden, Professor David
Authors: Mrowietz, U., Bachelez, H., Burden, A. D., Rissler, M., Sieder, C., Orsenigo, R., and Jagiello, P.
College/School:College of Medical Veterinary and Life Sciences > School of Infection & Immunity
Journal Name:Journal of the American Academy of Dermatology
Publisher:Elsevier
ISSN:0190-9622
ISSN (Online):1097-6787
Published Online:18 June 2020
Copyright Holders:Copyright © 2020 by the American Academy of Dermatology, Inc
First Published:First published in Journal of the American Academy of Dermatology 84(2): 552-554
Publisher Policy:Reproduced under a Creative Commons License

University Staff: Request a correction | Enlighten Editors: Update this record

Deposit and Record Details